ARCHIVES

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

This article is from The Cancer Letter archive.

Vol. 38 No. 25 | June 22, 2012

Download PDF Visit The Full Archive

Related Articles

Cooperative Group Chairman Unhappy Over Exclusion From Funding at Recommended Levels

December 2, 1983

MGMT Gene Can Determine Disease Aggressiveness

June 24, 2011

Rogers Eyes Saccharin Ban

March 18, 1977

Keytruda Granted Approval In Metastatic Melanoma

September 26, 2014

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

May 21, 1999

In Brief: La Jolla Foundation Receives Donated Buildings; Sinks Named Medical Director, Middlesex Hospital

April 27, 1990